Simon Thompson 

Kromek turns inflexion point

Simon Thompson

Simon Thompson
Kromek turns inflexion point

Dr Arnab Basu, chief executive of Sedgefield-based Kromek (KMK:24.25p), a radiation detection technology company focused on the medical, security and nuclear markets, was in bullish mood during our results call. He had reason to be as his company has just hit a major inflexion point, having posted cash profits of almost £500,000 on revenues up a third to £11.9m in the 12 months to end April 2018.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe to Investors Chronicle

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now